Hangzhou (1)

Primary Central Nervous System Lymphoma (1)

Refractory Central Nervous System Lymphoma (1)

Relapsed Primary Central Nervous System Lymphoma (1)

Active, not recruiting (1)

n/a (1)

Second Affiliated Hospital, School of Medicine, Zhejiang University (1)

nivolumab (1)

drug (1)

Other (1)

Interventional (1)

relapsed primary central nervous system lymphoma

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Active, not recruiting

Jul 3, 2022